Valuation Myriad Genetics, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 04:00:00 2026-07-14 pm EDT			5-day change	1st Jan Change
6.040 ^USD	+3.07%		+3.07%	-1.79%

Jul. 02	Myriad Genetics Publishes Large-Scale Meta-Analysis Demonstrating Prognostic Performance of Prolaris Biopsy Test in Localized Prostate Cancer	CI
Jun. 23	Myriad Genetics, Inc. Announces Resignation of Daniel M. Skovronsky from Director, Effective June 17, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,204	1,176	1,697	1,248	573.3	570.5	-	-
Change	-	-46.65%	44.34%	-26.46%	-54.07%	-0.49%	-	-
Enterprise Value (EV)	1,864	1,061	1,595	1,185	543.6	570.5	570.5	570.5
Change	-	-43.09%	50.32%	-25.67%	-54.14%	4.95%	0%	0%
P/E	-78.9x	-10.4x	-6.02x	-9.72x	-1.56x	-7.95x	-11.4x	-12.5x
PBR	2.28x	1.33x	2.2x	1.79x	1.56x	-	-	-
PEG	-	-0x	-0x	0.2x	-0x	0.1x	0.4x	1.47x
Capitalization / Revenue	3.19x	1.73x	2.25x	1.49x	0.7x	0.66x	0.62x	0.59x
EV / Revenue	0x	0x	0x	0x	0x	0.66x	0.62x	0.59x
EV / EBITDA	0x	-0x	-0x	0x	0x	15.5x	11.9x	10.7x
EV / EBIT	0x	-0x	-0x	0x	0x	49.7x	20.2x	10.8x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.35	-1.39	-3.18	-1.41	-3.95	-0.76	-0.53	-0.485
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	690.6	678.4	753.2	837.6	824.5	863.6	915.8	970.1
EBITDA ¹	71.9	-21	-6.3	40.4	38.9	36.81	47.81	53.23
EBIT ¹	9.1	-32.8	-25.5	21.8	15.1	11.48	28.31	52.9
Net income ¹	-27.2	-112	-263.3	-127.3	-365.9	-71.48	-50.98	-47.29
Net Debt	-339.8	-114.9	-102.4	-62.8	-29.7	-	-	-
Reference price ²	27.600	14.510	19.140	13.710	6.150	6.040	6.040	6.040
Nbr of stocks (in thousands)	79,855	81,034	88,669	91,035	93,214	94,448	-	-
Announcement Date	2/24/22	2/28/23	2/27/24	2/24/25	2/23/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MYRIAD GENETICS, INC.	-7.95x	-	-	-.--%	570M
GUARDANT HEALTH, INC.	-55.19x	16.55x	-121.14x	-.--%	21.23B
BIOMÉRIEUX	16.87x	1.91x	7.96x	1.53%	9.48B
LANTHEUS HOLDINGS, INC.	23.84x	4.36x	12.31x	-	6.66B
10X GENOMICS, INC.	-56.23x	8.68x	-72.86x	-.--%	5.81B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	18.7x	6.41x	14.49x	3.08%	5.05B
CARIS LIFE SCIENCES, INC.	167.37x	4.32x	28.31x	-.--%	4.79B
DIASORIN S.P.A.	20.3x	3.56x	11.08x	1.87%	4.23B
AUTOBIO DIAGNOSTICS CO., LTD.	16x	-	-	4.01%	2.69B
Average	15.97x	6.54x	-17.12x	1.31%	6.72B
Weighted average by Cap.	-2.63x	9.03x	-45.10x	0.91%